Catalyst
Slingshot members are tracking this event:
Final Decision Expected from European Commission in ~60 Days on Sanofi's (SNY) Suliqua in Type 2 Diabetes
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SNY |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 18, 2017
Occurred Source:
http://mediaroom.sanofi.com/suliquatm-approved-in-the-european-union-for-the-treatment-of-adults-with-type-2-diabetes/
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Final Decision, European Comission, Suliqua, Type 2 Diabetes
